A Strength-Based Employment Maintenance Program for Individuals on the Autism Spectrum
NCT ID: NCT06255925
Last Updated: 2025-03-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
30 participants
INTERVENTIONAL
2023-01-01
2026-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Strength-Based Intervention to Improve Job Interview Skills in Young Adults in a Community Setting
NCT06380569
KF STRIDE to Improve Job Interview Skills
NCT04820647
A Strength-Based Intervention to Improve Job Interview Skills in Neurodiverse Young Adults
NCT06479850
Examining the Effects of a Job Entry Intervention
NCT04771338
Evaluation and Refinement of KF-STRIDE Into the Interview!
NCT07168941
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment Group
In this arm, participants would participate in in an intervention program that uses character strengths to improve job maintenance skills in young adults.
KF-STRIDE® Into Work!
Treatment group will receive 10 web based sessions of a strength-based training tool(once or twice a week). Sessions are approximately 60 minutes long.
Control Group
In this arm, participants are services as usual and will participate in their regular activities.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
KF-STRIDE® Into Work!
Treatment group will receive 10 web based sessions of a strength-based training tool(once or twice a week). Sessions are approximately 60 minutes long.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Between the ages of 14-26
* Speaks English well and at a 4th grade reading level
Exclusion Criteria
* Has a history of significant psychiatric illness(like schizophrenia or psychosis)
* Has uncontrolled seizures or other unstable medical complications
14 Years
26 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kessler Foundation
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Helen Genova, Ph. D.
Role: PRINCIPAL_INVESTIGATOR
Kessler Foundation
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kessler Foundation
East Hanover, New Jersey, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Helen Genova, Ph. D.
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
E-1199-22
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.